Literature DB >> 28866814

From mechanisms to therapy: RNA processing's impact on human genetics.

Luiz O Penalva1, Jeremy R Sanford2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28866814     DOI： 10.1007/s00439-017-1841-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


× No keyword cloud information.
  26 in total

Review 1.  Pre-mRNA splicing and human disease.

Authors:  Nuno André Faustino; Thomas A Cooper
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

Review 2.  Context-dependent control of alternative splicing by RNA-binding proteins.

Authors:  Xiang-Dong Fu; Manuel Ares
Journal:  Nat Rev Genet       Date:  2014-08-12       Impact factor: 53.242

Review 3.  How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy.

Authors:  N N Singh; M D Howell; E J Androphy; R N Singh
Journal:  Gene Ther       Date:  2017-05-09       Impact factor: 5.250

Review 4.  Functional consequences of developmentally regulated alternative splicing.

Authors:  Auinash Kalsotra; Thomas A Cooper
Journal:  Nat Rev Genet       Date:  2011-09-16       Impact factor: 53.242

5.  Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.

Authors:  Endre Sebestyén; Michał Zawisza; Eduardo Eyras
Journal:  Nucleic Acids Res       Date:  2015-01-10       Impact factor: 16.971

6.  Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.

Authors:  Eric T Wang; Neal A L Cody; Sonali Jog; Michela Biancolella; Thomas T Wang; Daniel J Treacy; Shujun Luo; Gary P Schroth; David E Housman; Sita Reddy; Eric Lécuyer; Christopher B Burge
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

7.  Splicing of oskar RNA in the nucleus is coupled to its cytoplasmic localization.

Authors:  Olivier Hachet; Anne Ephrussi
Journal:  Nature       Date:  2004-04-29       Impact factor: 49.962

8.  Spliced segments at the 5' terminus of adenovirus 2 late mRNA.

Authors:  S M Berget; C Moore; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

9.  Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.

Authors:  Sunniva Stordal Bjørklund; Anshuman Panda; Surendra Kumar; Michael Seiler; Doug Robinson; Jinesh Gheeya; Ming Yao; Grethe I Grenaker Alnæs; Deborah Toppmeyer; Margit Riis; Bjørn Naume; Anne-Lise Børresen-Dale; Vessela N Kristensen; Shridar Ganesan; Gyan Bhanot
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

10.  A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.

Authors:  Angela N Brooks; Peter S Choi; Luc de Waal; Tanaz Sharifnia; Marcin Imielinski; Gordon Saksena; Chandra Sekhar Pedamallu; Andrey Sivachenko; Mara Rosenberg; Juliann Chmielecki; Michael S Lawrence; David S DeLuca; Gad Getz; Matthew Meyerson
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.